SPONSOR
Qilu Hospital of Shandong University
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 4
Qilu Hospital of Shandong University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Bladder Cancer, Carcinoma, Hepatocellular, Arthritis, Rheumatoid.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Qilu Hospital of Shandong University
How many clinical trials has Qilu Hospital of Shandong University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Qilu Hospital of Shandong University, of which 3 are actively recruiting participants. These trials cover conditions including Bladder Cancer, Carcinoma, Hepatocellular, Arthritis, Rheumatoid. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qilu Hospital of Shandong University research focus on?
Qilu Hospital of Shandong University clinical trials span Bladder Cancer, Carcinoma, Hepatocellular, Arthritis, Rheumatoid. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qilu Hospital of Shandong University clinical trial?
To participate in a Qilu Hospital of Shandong University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qilu Hospital of Shandong University trials with current recruitment status updated daily.
Clinical Trials by Qilu Hospital of Shandong University
NCT07379255
Recruiting
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
Bladder Cancer
NCT06454578 Phase 2
Recruiting
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Carcinoma, Hepatocellular
NCT05626348 Phase 4
Recruiting
The Clinical Efficacy of Immunomodulators in RA Patients
Arthritis, Rheumatoid
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology